Nasdaq News

(RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services, reported higher revenue and a narrower loss for the six months ended June 30, 2026.

(RTTNews) - Shares of Bassett Furniture Inc. (BSET) gained around 10 percent in the after-market activity on the Nasdaq after the company reported higher profit in the third quarter of fiscal 2026, supported by increased revenue, expense control and tariff refunds.

(RTTNews) - Pfizer Inc. (PFE) reported Thursday that its ongoing Phase 2 study of investigational Tilrekimig met its primary endpoint in adults with moderate to severe atopic dermatitis.

Key PointsThe market has been reaching record highs, despite multiple headwinds.

(RTTNews) - H. Lundbeck A/S (HLBBF) announced headline results from the Phase IV THRIVE trial evaluating eptinezumab, an investigational humanised monoclonal antibody administered intravenously, in adults with migraine who had an inadequate response to one prior CGRP-targeting pr

(RTTNews) - Roche (RHHBY) announced new data from the VOYAGER study showing that Vabysmo (faricimab) continued to demonstrate effectiveness, durability and safety in real-world clinical practice across several major retinal diseases.

Key PointsA bull market is a great time to own stocks, as many may soar and will increase the value of your portfolio.

(RTTNews) - Tevogen Inc. (TVGN), a healthcare company, said it received notice from Nasdaq on September 29, 2026, confirming that it had regained compliance with the $50 million minimum market value of listed securities requirement for continued listing on the Nasdaq Global Marke

Key PointsCompeting in AI has come with tremendous demands for capital spending.

(RTTNews) - Swiss drug major Roche Holding AG (RHHBY, RO.SW, ROG.SW) announced Thursday that giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA.

(RTTNews) - Thursday, Roche (RHHBY) reported new data from the VOYAGER study showing that Vabysmo (faricimab) delivered durable effectiveness and a consistent safety profile in patients with wet age-related macular degeneration (AMD), diabetic macular edema (DME) and macular edem

(RTTNews) - Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) on Thursday announced an expanded global collaboration to develop and commercialise four next-generation, long-acting immunology antibodies targeting type 2 inflammation.

(RTTNews) - Sentiment in European stock markets is expected to remain weak on Thursday amidst a hardening in global bond yields. Ten-year bond yields have increased more than a quarter percent in Germany, France, U.K., as well as Spain. The easing in crude oil prices, the momentu

Key PointsGE Vernova's backlog and orders are growing faster than expected.

(RTTNews) - Paramount Skydance Corp. (PSKY) and Warner Bros. Discovery, Inc. (WBD) announced that their proposed merger is expected to close on October 6, subject to customary closing conditions.

(RTTNews) - Uranium producer Cameco Corp. (CCJ) said the U.S. and South Korea announced a framework under a prior Memorandum of Understanding that anticipates a $120 billion investment by Korea to fund the construction of nuclear reactors using Westinghouse technology and designs

(RTTNews) - The Boeing Company (BA), the aerospace and defense major, Wednesday announced that it has secured an order of eight 777-8 Freighters and two 777 Freighters from the African carrier Ethiopian Airlines to expand its cargo fleet.

(RTTNews) - Fresenius SE & Co. KGaA (FRE.DE), a health care company, on Thursday announced that it has acquired the remaining 45% stake in mAbxience Holding S.L. for up to 750 million euros.

Key PointsAMD closed with a market cap above $1 trillion for the first time on Sept. 21, 2026.

(RTTNews) - Wednesday, Corvus Pharmaceuticals, Inc. (CRVS) reported the initiation of Phase 1b clinical trial of Soquelitinib in patients with moderate to severe Hidradenitis suppurativa, with enrollment underway.